investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

KIR in adaptive immunity: in vivo relevance for human disease

Becca Asquith

0 Collaborator(s)

Funding source

Medical Research Council (MRC)

No posts

Related projects

Richard Aplenc

Genetic Predictors of AML Treatment Response

Leukaemia

Hematology and hematologic malignancies

Scott H Kaufmann

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Roland B Walter

Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML

Leukaemia

Hematology and hematologic malignancies

Thomas J Kipps

Chronic Lymphocytic Leukemia Research Consortium

Leukaemia

Hematology and hematologic malignancies

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Ravi Bhatia

Microenvironmental Regulation of Leukemia Stem Cells

Leukaemia

Hematology and hematologic malignancies

Karin L Gaensler

Efficacy and Safety of Novel CD80 IL15 IL15Ra Expressing Autologous AML Vaccines

Leukaemia

Hematology and hematologic malignancies

Ronald Hoffman

Myeloproliferative Disorders (MPD) Research Consortium

Leukaemia

Hematology and hematologic malignancies

Leona W Ayers

Mid-Region Aids and Cancer Specimen Resource Consortium

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies